INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 182 filers reported holding INARI MED INC in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,523,951 | +12.5% | 23,302 | 0.0% | 0.16% | +39.6% |
| Q2 2023 | $1,354,778 | -6.4% | 23,302 | -0.6% | 0.11% | -24.5% |
| Q1 2023 | $1,446,692 | +25.0% | 23,432 | +28.7% | 0.15% | +42.7% |
| Q4 2022 | $1,156,919 | -44.0% | 18,202 | -36.0% | 0.10% | -47.7% |
| Q3 2022 | $2,067,000 | +6.8% | 28,452 | +7.6% | 0.20% | +10.1% |
| Q2 2022 | $1,935,000 | -19.7% | 26,452 | -0.6% | 0.18% | -3.2% |
| Q1 2022 | $2,411,000 | +5.2% | 26,604 | +6.0% | 0.18% | +2.2% |
| Q4 2021 | $2,291,000 | +12.5% | 25,100 | -0.0% | 0.18% | -2.2% |
| Q3 2021 | $2,036,000 | +91.5% | 25,106 | +120.4% | 0.18% | +86.9% |
| Q2 2021 | $1,063,000 | +9.5% | 11,393 | +25.5% | 0.10% | +2.1% |
| Q1 2021 | $971,000 | +58.9% | 9,075 | +29.6% | 0.10% | +38.6% |
| Q4 2020 | $611,000 | +57.5% | 7,000 | -12.5% | 0.07% | +29.6% |
| Q2 2020 | $388,000 | – | 8,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 125,000 | $11,409,000 | 4.14% |
| SECTORAL ASSET MANAGEMENT INC | 163,550 | $14,927,000 | 2.25% |
| Lisanti Capital Growth, LLC | 81,460 | $7,435,000 | 1.08% |
| Pier Capital, LLC | 99,422 | $9,074,000 | 0.96% |
| Beck Bode, LLC | 33,384 | $3,047,000 | 0.76% |
| Nicholas Investment Partners, LP | 104,932 | $9,577,000 | 0.61% |
| CNA FINANCIAL CORP | 24,773 | $2,261,000 | 0.59% |
| NEXT CENTURY GROWTH INVESTORS LLC | 56,523 | $5,158,000 | 0.46% |
| HARBOURVEST PARTNERS LLC | 38,540 | $3,518,000 | 0.45% |
| Birchview Capital, LP | 7,000 | $639,000 | 0.41% |